Wednesday, December 01, 2021

NEWS

Cuba’s Soberana Plus vaccine protects against Covid-19 reinfection

Cuba’s Soberana Plus vaccine protects against Covid-19 reinfection

Havana, Apr 12 (Prensa Latina) A single dose of Cuba's vaccine candidate Soberana Plus can protect people against Covid-19 reinfection and improve their immune response to variants of the SARS-CoV-2 coronavirus, health authorities announced on Monday.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

At a press conference on Cuban television, Dr. Rolando Ochoa, a researcher with the Finlay Vaccines Institute (IFV) and project leader, explained that Soberana Plus has been designed for convalescents and as reinforcement for those who have been vaccinated with Soberana 02 in its phase III of clinical trials.

Soberana Plus was recently approved for phase II of clinical trials, and will be administered to 450 volunteers who suffered from Covid-19 with a mild, moderate or asymptomatic clinical history.

‘It will be a multicenter, adaptive study in parallel random groups, a double-blind and control study with a placebo,’ Ochoa noted.

The study involves patients aged 19-80 who were discharged from hospitals at least two months before receiving a single dose of Soberana Plus.

jg/jcm/cdg

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.